These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7233529)
1. Fatal response suggestive of graft-versus-host reaction following transplantation of spleen cells from allogeneic athymic (nude) donors. OKunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K Transplantation; 1981 Mar; 31(3):201-4. PubMed ID: 7233529 [TBL] [Abstract][Full Text] [Related]
2. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia. Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959 [TBL] [Abstract][Full Text] [Related]
3. Rapid viral induction of murine lymphomas in the graft-versus-host reaction. Cornelius EA J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity. Lapidot T; Lubin I; Terenzi A; Faktorowich Y; Erlich P; Reisner Y Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4595-9. PubMed ID: 2191295 [TBL] [Abstract][Full Text] [Related]
5. Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation. Slavin S; Fuks Z; Kaplan HS; Strober S J Exp Med; 1978 Apr; 147(4):963-72. PubMed ID: 25942 [TBL] [Abstract][Full Text] [Related]
6. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. Rolink AG; Pals ST; Gleichmann E J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218 [TBL] [Abstract][Full Text] [Related]
7. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment. Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257 [TBL] [Abstract][Full Text] [Related]
8. Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma. Truitt RL; Shih CC; LeFever AV Transplantation; 1986 Mar; 41(3):301-10. PubMed ID: 3513389 [TBL] [Abstract][Full Text] [Related]
9. Histocompatibility influence in allogeneic marrow transplantation therapy of murine viral leukemia. I.--Studies of the relative influence of major versus minor histocompatibility determinants. Meredith RF; Okunewick JP; Raikow RB; Brozovich BJ; Seeman PR; Magliere KC Biomedicine; 1981 Feb; 34(1):11-7. PubMed ID: 7013840 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients. Mayumi H; Himeno K; Tanaka K; Tokuda N; Fan JL; Nomoto K Transplantation; 1986 Oct; 42(4):417-22. PubMed ID: 3532453 [TBL] [Abstract][Full Text] [Related]
11. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells. Miller SC J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669 [TBL] [Abstract][Full Text] [Related]
12. Avoidance of graft versus host reactions in cured W-anemic mice. Harrison DE Transplantation; 1976 Jul; 22(1):47-51. PubMed ID: 7035 [TBL] [Abstract][Full Text] [Related]
13. Possibility of graft-vs-leukemia determinants independent of the major histocompatibility complex in allogeneic marrow transplantation. Meredith RF; Okunewick JP Transplantation; 1983 Apr; 35(4):378-85. PubMed ID: 6340292 [TBL] [Abstract][Full Text] [Related]
14. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation]. Zhao J; Zhao XY; Huang XJ Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278 [TBL] [Abstract][Full Text] [Related]
15. Delaying transplantation after total body irradiation is a simple and effective way to reduce acute graft-versus-host disease mortality after major H2 incompatible transplantation. Xun CQ; Tsuchida M; Thompson JS Transplantation; 1997 Jul; 64(2):297-302. PubMed ID: 9256191 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation across major histocompatibility barriers in mice. II. T cell requirement for engraftment in total lymphoid irradiation-conditioned recipients. Vallera DA; Soderling CC; Carlson GJ; Kersey JH Transplantation; 1982 Mar; 33(3):243-8. PubMed ID: 6121405 [TBL] [Abstract][Full Text] [Related]
17. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo. Shand FL Immunology; 1975 Dec; 29(6):953-65. PubMed ID: 325 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation in conventional mice: I. Effect of antibiotic therapy on long term survival of allogeneic chimeras. Heit H; Heit W; Kohne E; Fliedner TM; Hughes P Blut; 1977 Aug; 35(2):143-53. PubMed ID: 20185 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL/J mice. Vourka-Karussis U; Karussis D; Ackerstein A; Slavin S Exp Hematol; 1995 Mar; 23(3):196-201. PubMed ID: 7875238 [TBL] [Abstract][Full Text] [Related]